Managing Director of Genomic Health
Stephen Ogram is the UK Managing Director of Genomic Health – a Nasdaq-listed company focusing on genomic research specifically in cancer detection and diagnostics. Stephen has over 20 years’ experience in the pharmaceutical and healthcare industry, witnessing and encouraging the innovation of diagnostics in modern medicine. After graduating in biochemistry, he worked at companies including Johnson & Johnson, Roche and Bayer. He now oversees Genomic Health’s commercial, strategic and scientific operations in the UK and Ireland. Genomic Health’s diagnostic products have helped over a million patients worldwide.